The Analysis of the PI3K-AKT-mTOR Pathway and Mitochondria Modulation by a 2-Aminopyridine Compound Using the Metastatic Prostate Cancer Cell Line PC-3
Drugs and Drug Candidates · 02.03.2026 · 5 (1) · 18
DOI: 10.3390/ddc5010018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs and Drug Candidates, online erschienen am 02.03.2026. Verfasst von Talita Alvarenga Valdes und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, National Research Council, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brazil.
Abstract (Originalsprache)
Background
Prostate cancer is one of the most prevalent and deadly neoplasias in the male population. Despite the availability of therapies that increase the long-term survival of patients with localized tumors, metastatic prostate cancer is challenging to treat. A previous study revealed that the 2-aminopyridine derivative (named Neq0440) inhibited the PI3K-AKT-mTOR pathway and presented selective cytotoxicity toward the metastatic prostate cancer cell line PC-3.
Methods
Here, we further analyzed the mechanism of action of these molecules by using cell-based colorimetric, fluorometric, epifluorescence microscopy, and Western blot assays.
Results
Mitochondrial depolarization increased the AMPK level at 24 h inhibition with Neq0440, which led to the PI3K-AKT-mTOR pathway downregulation after 48 h. The phosphorylation was inhibited for AKT and the downstream quinases (S6RP and 4EBP1) from the PI3K-AKT-mTOR pathway, which can work together with the mitochondrial depolarization, lowering the pH of the medium, increasing ROS levels, and translocating the lysosomes toward the nucleus to trigger cell death.
Conclusions
Therefore, Neq0440 can be used as a lead compound to obtain derivatives with a novel anticancer mechanism of action.
Förderung
- São Paulo Research Foundation
- National Research Council
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brazil
Zitieren
APA
Valdes, T. A., Botelho, S. M., Lima, K., Montanari, C. A., Neto, J. A. M., & Leitão, A. (2026). The Analysis of the PI3K-AKT-mTOR Pathway and Mitochondria Modulation by a 2-Aminopyridine Compound Using the Metastatic Prostate Cancer Cell Line PC-3. Drugs and Drug Candidates, 5(1), 18. https://doi.org/10.3390/ddc5010018
Vancouver
Valdes TA, Botelho SM, Lima K, Montanari CA, Neto JAM, Leitão A. The Analysis of the PI3K-AKT-mTOR Pathway and Mitochondria Modulation by a 2-Aminopyridine Compound Using the Metastatic Prostate Cancer Cell Line PC-3. Drugs and Drug Candidates. 2026;5(1):18. doi:10.3390/ddc5010018
BibTeX
@article{Valdes2026,
author = {Valdes, Talita Alvarenga and Botelho, Sabrina Mendes and Lima, Keli and Montanari, Carlos Alberto and Neto, João Agostinho Machado and Leitão, Andrei},
title = {The Analysis of the PI3K-AKT-mTOR Pathway and Mitochondria Modulation by a 2-Aminopyridine Compound Using the Metastatic Prostate Cancer Cell Line PC-3},
journal = {Drugs and Drug Candidates},
year = {2026},
volume = {5},
number = {1},
pages = {18},
doi = {10.3390/ddc5010018}
}
EUVIMED